HBORF Stock Price, News & Analysis
Company Description
HBORF (OTC: HBORF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $86.2M.
HBORF stock has declined 7.5% over the past year.
This page provides a comprehensive overview of HBORF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HBORF (HBORF) stock. Over the past 12 months, the stock has lost 7.5%. At a market capitalization of $86.2M, HBORF is classified as a micro-cap stock with approximately 252.4M shares outstanding.
Latest News
HBORF has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include management, earnings, acquisition. View all HBORF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HBORF Company Profile & Sector Positioning
HBORF (HBORF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HBORF often look at related companies in the same sector, including (REPH), (LSFP), (GNTW), Gage Growth (GAEGF), and (MNKPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HBORF's relative position within its industry.